STOCK TITAN

Caring Brands, Inc. Form 4 Filings

CABR NASDAQ

Every Form 4 that Caring Brands, Inc. (CABR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CABR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CABR filings page.

Rhea-AI Summary

John Brian reported disposition transactions in this Form 4 filing.

Caring Brands, Inc. director and Interim CFO John Brian reported an entity-related restructuring involving 150,000 shares of common stock on July 23, 2026. The transaction reflects the issuer’s redemption of these shares at approximately $1.00 per share from BK Investments LLC, an entity owned by him. Following this redemption, he reports direct ownership of 600,000 shares of Caring Brands common stock.

Rhea-AI Summary

Caring Brands, Inc. Chief Executive Officer Dr. Glynn Wilson reported a disposition of 1,500,000 shares of common stock back to the company. The shares were redeemed at approximately $0.50 per share under a Share Redemption Agreement signed on March 19, 2026.

After this issuer redemption, Dr. Wilson beneficially owns 500,000 shares of common stock and 172,592 restricted stock units, none of which have vested. He therefore continues to hold a meaningful equity stake that aligns his interests with other shareholders.

Rhea-AI Summary

Caring Brands, Inc. director John Brian reported a large share redemption transaction. He disposed of 1,250,000 shares of Common Stock at approximately $1.00 per share in a redemption by the company under a Share Redemption Agreement signed on March 19, 2026. After this disposition to the issuer, he directly holds 750,000 shares of Caring Brands common stock.

Rhea-AI Summary

Caring Brands, Inc. reported that director Hector W. Alila received a grant of stock options to purchase 25,000 shares of common stock at an exercise price of $1.13 per share on December 11, 2025.

The options vested immediately on the grant date and are scheduled to expire on December 11, 2030, leaving 25,000 derivative securities beneficially owned directly by the reporting person after the transaction. The grant was approved by the company’s board of directors under its equity incentive plan following a recommendation from the compensation committee.

Rhea-AI Summary

Caring Brands, Inc. reported an insider equity award involving a director who is also a 10% owner. On December 11, 2025, the board, following a recommendation from the compensation committee, approved a grant of 100,000 stock options under the company’s equity incentive plan, with an exercise price of $1.243 per share and no cost to acquire the options themselves.

The options are scheduled to fully vest on June 11, 2026, provided the reporting person continues to serve the company, and they are set to expire on December 11, 2030. After this transaction, the reporting person beneficially owns 100,000 stock options and also holds 2,000,000 shares of Caring Brands common stock.

Rhea-AI Summary

Caring Brands, Inc. director Christopher Melton reported receiving a stock option grant from the company. On December 11, 2025, the board of directors, following a recommendation from the compensation committee, approved an option for Melton to buy 25,000 shares of common stock at an exercise price of $1.13 per share under the company’s equity incentive plan.

The options vested immediately on December 11, 2025 and expire on December 11, 2030. Following this grant, Melton beneficially owns 25,000 stock options directly.

Rhea-AI Summary

Caring Brands, Inc. director Christopher Matthew Galeta received a stock option grant on December 11, 2025 under the company’s equity incentive plan. The award covers 25,000 stock options with an exercise price of $1.13 per share, giving him the right to buy 25,000 shares of common stock at that price.

The options were approved by the Board of Directors at the recommendation of the Compensation Committee and vest immediately as of December 11, 2025. After this grant, Galeta beneficially owns 25,000 derivative securities in the form of these stock options, which expire on December 11, 2030.

Rhea-AI Summary

Caring Brands, Inc. disclosed that its Chief Executive Officer, director, and 10% owner, Dr. Glynn Wilson, received two restricted stock unit (RSU) grants of common stock on December 11, 2025 under the company’s equity incentive plan. The first award covers 126,720 RSUs that fully vest on June 11, 2026, and the second covers 45,872 RSUs that fully vest on December 11, 2026, in each case conditioned on Dr. Wilson’s continued service with the company.

Both grants are shown at a price of $0 per share, reflecting equity compensation rather than an open‑market purchase. Following these awards, Dr. Wilson is reported as beneficially owning 2,172,592 shares of Caring Brands common stock, which includes his prior ownership of 2,000,000 shares.

Rhea-AI Summary

Caring Brands, Inc. reported that Chief Financial Officer Tyler Thomas Moore received equity awards totaling 300,000 restricted stock units of common stock on December 11, 2025 under its equity incentive plan.

The grants consist of 270,000 restricted stock units that fully vest on June 11, 2026 and 30,000 restricted stock units that fully vest on December 11, 2026, in each case subject to his continued service with the company. Following these awards, he beneficially owns 300,000 shares of common stock directly.